camptothecin has been researched along with securinine in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Batista-Gonzalez, A; Brunhofer, G; Fallarero, A; Gopi Mohan, C; Karlsson, D; Shinde, P; Vuorela, P | 1 |
| Ayad, T; Fahy, J; Maillos, P; Perez, M; Poughon, V; Ratovelomanana-Vidal, V | 1 |
| Chang, YQ; Chen, WM; Hou, W; Jiang, RW; Lin, H; Lin, J; Liu, X; Peng, CK; Sun, PH; Wang, ZY; Xu, J | 1 |
| Banwell, MG; Chen, WM; Hou, W; Lin, H; Lin, J; Sun, PH; Wang, ZY; Zeng, T | 1 |
4 other study(ies) available for camptothecin and securinine
| Article | Year |
|---|---|
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
Topics: Acetylcholinesterase; Amyloid beta-Peptides; Benzophenanthridines; Binding Sites; Butyrylcholinesterase; Catalytic Domain; Cholinesterase Inhibitors; Humans; Isoquinolines; Kinetics; Molecular Docking Simulation; Structure-Activity Relationship | 2012 |
Synthesis and Antiproliferative and Metabolic Evaluations of Novel Securinine Derivatives.
Topics: | 2016 |
Novel securinine derivatives as topoisomerase I based antitumor agents.
Topics: Antineoplastic Agents; Azepines; Cell Line, Tumor; Cell Proliferation; DNA Cleavage; DNA Topoisomerases, Type I; Drug Design; Heterocyclic Compounds, Bridged-Ring; Humans; Lactones; Models, Molecular; Piperidines; Protein Conformation; Structure-Activity Relationship; Topoisomerase I Inhibitors | 2016 |
Novel bivalent securinine mimetics as topoisomerase I inhibitors.
Topics: | 2017 |